This research was developed within the LAQV-REQUIMTE (UIDB/QUI/50006/2020) and Molecular Physical-Chemistry R & D Unit (UIDB/00070/2020, UIDP/00070/2020 and SFRH/BD/08869/2021) financed by the Portuguese Foundation for Science and Technology (FCT). Martin Vojtek thanks the Portuguese Foundation for Science and Technology (FCT) and the PhD Program in Medicines and Pharmaceutical Innovation (i3DU) for the PhD grants PD/BD/135460/2017 and COVID/BD/152492/2022, funded by the European Social Fund of the European Union and national funds FCT/MCTES.

View Statistics Email Alert RSS Feed

Primary Data

Project title
This research was developed within the LAQV-REQUIMTE (UIDB/QUI/50006/2020) and Molecular Physical-Chemistry R & D Unit (UIDB/00070/2020, UIDP/00070/2020 and SFRH/BD/08869/2021) financed by the Portuguese Foundation for Science and Technology (FCT). Martin Vojtek thanks the Portuguese Foundation for Science and Technology (FCT) and the PhD Program in Medicines and Pharmaceutical Innovation (i3DU) for the PhD grants PD/BD/135460/2017 and COVID/BD/152492/2022, funded by the European Social Fund of the European Union and national funds FCT/MCTES.

Publications
(All)

Results 1-1 of 1 (Search time: 0.001 seconds).

Issue DateTitleAuthor(s)TypeAccess
110-Apr-2023Pd(II) and Pt(II) Trinuclear Chelates with Spermidine: Selective Anticancer Activity towards TNBC-Sensitive and -Resistant to CisplatinVojtek, Martin; Martins, Clara B. ; Ramos, Raquel ; Duarte, Sara Gomes; Ferreira, Isabel M. P. L. V. O.; Carvalho, Ana L. M. Batista de ; Marques, M. P.aula M. ; Diniz, Carmen articleopenAccess